
#Industry News
International Stomach Care Day
Combating Silent Threats in Stomach Health: Early Detection and Personalized Care
Let’s talk about something that affects millions globally — stomach health.
From indigestion and ulcers to gastric cancer and Helicobacter pylori (H. pylori) infection, stomach-related diseases continue to pose serious health burdens worldwide. Early detection and personalized diagnostics are critical for timely intervention and improved patient outcomes.
Gastric Cancer: Early Markers, Smarter Diagnosis
Gastric cancer often presents silently in its early stages, making tumor marker screening an essential part of preventive care. At #KHB, we offer a comprehensive biomarker detection solutions to support early diagnosis, disease monitoring, and treatment planning.
Tumor Markers Include:
• PGI, PGII, G-17 – Indicators of gastric mucosal atrophy and function
• CEA, CA19-9, CA72-4 – Common markers for gastrointestinal tumors
• CA125, Cyfra21-1, CA153, AFP – Supporting broader differential diagnosis
Detection Methods: #Biochemistry, #CLIA, #ELISA
H. pylori: Precision Testing for Personalized Therapy
Chronic infection with Helicobacter pylori is a major risk factor for gastritis, ulcers, and gastric cancer. But treatment isn’t one-size-fits-all — antibiotic resistance is on the rise, and guiding treatment with resistance gene testing is more important than ever.
With #Tianlong’s advanced #molecular diagnostics, we can:
✔ Detect H. pylori (16s rRNA) with high sensitivity and specificity
✔ Test for resistance genes related to key antibacterial drugs:
• Metronidazole
• Clarithromycin
• Amoxicillin
• Levofloxacin
• Nitrofurantoin
Why it matters:
Traditional empirical therapy often fails due to rising drug resistance. Our solution provides data-driven treatment recommendations, improving efficacy, reducing resistance development, and enhancing patient care.
On this International Stomach Care Day, we’re proud to contribute to a future where diagnostics are earlier, smarter, and more personalized.